葡萄膜炎并发白内障术后前房注射地塞米松的疗效观察

Clinical research on anterior chamber injection of dexamethasone after cataract surgery with uveitis

目的:探索白内障摘除术后前房注射0.1mL地塞米松对葡萄膜炎并发白内障患者术后的影响。方法:试验组术后前房注射0.1mL地塞米松,对照组前房未注射地塞米松,观察两组术后炎症反应。结果:术后前2d两组患者视力间差别有统计学意义(P<0.05),术后第1d角膜水肿程度两组间有统计学差异(P<0.05),前房闪辉差异有统计学意义(P<0.05),且试验组术后患者视力提高者百分比高于对照组。结论:葡萄膜炎并发白内障患者行白内障超声乳化+人工晶状体植入术,术毕前房注射0.1mL地塞米松者可减轻短期术后炎症反应,可更早提高患者视力,对患者术后短期眼压未见明显影响。

AIM： To explore cataract surgery complication of the anterior chamber injection 0. 1 mL dexamethasone for uveitis complicated cataract patients. METHODS： The experimental group was injected 0. lmL dexamethasone to anterior chamber at the end of phacoemulsification （ Phaco ） ＋ intraocular lens （ IOL ） implantation, while the control group did not. And the different postoperative inflammation between them was observed. RESULTS： The differences of visual acuity between the two groups on the first two days after operation were statistically significant （ P 〈 0. 05 ）. The postoperative corneal edema and anterior chamber flare between the two groups in the first day were different（ P〈0.05）. And the percentage of the experimental group postoperative visual acuity improved was higher than that of the control group. CONCLUSION： it can reduce short-term postoperative inflammation, improve visual acuity earlier and do not impact the short-term postoperative intraocular pressure that uveitis complicated cataract was injected O. lmL dexamethasone to anterior chamber at the end of Phaco＋lOL. ~ KEYWORDS ： uveitis; concurrency cataract; dexamethasone; anterior chamber injection